Phosphate and betamethasone acetate, 2 ml.    (DrugBank: Betamethasone, Acetate, Phosphate)

1 disease
IDDisease name (Link within this page)Number of trials
235Hypoparathyroidism1

235. Hypoparathyroidism    [ 67 clinical trials,   112 drugs,   (DrugBank: 24 drugs),   4 drug target genes,   5 drug target pathways]
Searched query = "Hypoparathyroidism", "Accessory thyroid hypergasia disease"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
1 / 67 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT02652884
(ClinicalTrials.gov)
January 20165/1/2016Steroids in the Postoperative Transient Hypoparathyroidism Total ThyroidectomyEvaluation of Potential Benefits of Using Steroids in the Postoperative Transient Hypoparathyroidism Total ThyroidectomyTransient HypoparathyroidismDrug: phosphate and betamethasone acetate, 2 mL.;Drug: saline 0.9% NaClHospital Italiano de Buenos AiresNULLRecruiting18 YearsN/ABoth110Phase 4Argentina